BPTS

Biophytis SA American Depositary Share (0.01 Euro)
BPTS

Delisted

BPTS was delisted on the 25th of April, 2024.

Back to rankings
 

About: Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Employees: 24

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™